Literature DB >> 6563877

Cross-resistance between methicillin and cephalosporins for staphylococci: a general assumption not true for cefamandole.

R F Frongillo, P Bianchi, A Moretti, M B Pasticci, S Ripa, S Pauluzzi.   

Abstract

The antibacterial activity of cefamandole was evaluated against 120 methicillin-susceptible and methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococcal strains, using both large (10(8) CFU per ml) and small (10(4) CFU per ml) inocula. Cefamandole appeared superior to cephalothin against methicillin-resistant strains, displaying at 10 micrograms/ml a bacteriostatic and for some strains a bactericidal action against a large inoculum of bacteria.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6563877      PMCID： PMC185613          DOI： 10.1128/AAC.25.5.666

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  15 in total

1.  Clinical, epidemiologic and bacteriologic observations of an outbreak of methicillin-resistant Staphylococcus aureus at a large community hospital.

Authors:  J J Klimek; F J Marsik; R C Bartlett; B Weir; P Shea; R Quintiliani
Journal:  Am J Med       Date:  1976-09       Impact factor: 4.965

2.  Chemical and physical factors influencing methicillin resistance of Staphylococcus aureus and Staphylococcus epidermidis.

Authors:  L D Sabath
Journal:  J Antimicrob Chemother       Date:  1977-11       Impact factor: 5.790

3.  Can methicillin-resistant strains of Staphylococcus aureus be treated with methicillin?

Authors:  R W Lacey
Journal:  Lancet       Date:  1974-01-19       Impact factor: 79.321

4.  In vitro activity of cephalosporins against methicillin-resistant, coagulase-negative staphylococci.

Authors:  M Laverdiere; P Peterson; J Verhoef; D N Williams; L D Sabath
Journal:  J Infect Dis       Date:  1978-03       Impact factor: 5.226

5.  Methicillin-resistant staphylococci 1965-75.

Authors:  F H Kayser
Journal:  Lancet       Date:  1975-10-04       Impact factor: 79.321

6.  An outbreak of infections caused by strains of Staphylococcus aureus resistant to methicillin and aminoglycosides. I. Clinical studies.

Authors:  K Crossley; D Loesch; B Landesman; K Mead; M Chern; R Strate
Journal:  J Infect Dis       Date:  1979-03       Impact factor: 5.226

7.  Use of a heavy inoculum in the in vitro evaluation of the anti-staphylococcal activity of 19 cephalosporins.

Authors:  M Laverdiere; D Welter; L D Sabath
Journal:  Antimicrob Agents Chemother       Date:  1978-04       Impact factor: 5.191

8.  Activity of cephalosporins against methicillin-susceptible and methicillin-resistant, coagulase-negative staphylococci: minimal effect of beta-lactamase.

Authors:  J F John; W F McNeill
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

9.  Synergy of vancomycin plus cefazolin or cephalothin against methicillin-resistance Staphylococcus epidermidis.

Authors:  W T Siebert; N Moreland; T W Williams
Journal:  J Infect Dis       Date:  1979-04       Impact factor: 5.226

10.  Antimicrobial susceptibility and selection of resistance among Staphylococcus epidermidis isolates recovered from patients with infections of indwelling foreign devices.

Authors:  G L Archer
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191
View more
  19 in total

1.  Characterization of resistance phenotype and cephalosporin activity in oxacillin-resistant Staphylococcus aureus.

Authors:  M Mateos-Mora; C C Knapp; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

2.  Rationale for eliminating Staphylococcus breakpoints for β-lactam agents other than penicillin, oxacillin or cefoxitin, and ceftaroline.

Authors:  Jennifer Dien Bard; Janet A Hindler; Howard S Gold; Brandi Limbago
Journal:  Clin Infect Dis       Date:  2014-01-22       Impact factor: 9.079

3.  Activity of LY146032 compared with that of methicillin, cefazolin, cefamandole, cefuroxime, ciprofloxacin, and vancomycin against staphylococci as determined by kill-kinetic studies.

Authors:  C W Stratton; C Liu; L S Weeks
Journal:  Antimicrob Agents Chemother       Date:  1987-08       Impact factor: 5.191

4.  Effects of subinhibitory concentrations of vancomycin or cefamandole on biofilm production by coagulase-negative staphylococci.

Authors:  W M Dunne
Journal:  Antimicrob Agents Chemother       Date:  1990-03       Impact factor: 5.191

Review 5.  Methicillin-resistant staphylococci: detection methods and treatment of infections.

Authors:  C J Hackbarth; H F Chambers
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191

6.  Antimicrobial prophylaxis of experimental endocarditis caused by Staphylococcus epidermidis.

Authors:  L M Baddour; M M Hill; A M Felty-Duckworth
Journal:  Infection       Date:  1989 Mar-Apr       Impact factor: 3.553

7.  Salt-supplemented medium for testing methicillin-resistant staphylococci with newer beta-lactams.

Authors:  J H Jorgensen; J S Redding; L A Maher; P E Ramirez
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

8.  In vitro susceptibilities of four species of coagulase-negative staphylococci.

Authors:  R J Fass; V L Helsel; J Barnishan; L W Ayers
Journal:  Antimicrob Agents Chemother       Date:  1986-10       Impact factor: 5.191

9.  Inoculum effect on growth-delay time of oxacillin-resistant strains of Staphylococcus aureus and Staphylococcus epidermidis exposed to cefamandole, cefazolin, and cefuroxime.

Authors:  E Yourassowsky; M P van der Linden; F Crokaert
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

10.  Relationship between cefamandole and cefuroxime activity against oxacillin-resistant Staphylococcus epidermidis and oxacillin resistance phenotype.

Authors:  G L Woods; C C Knapp; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.